On December 10, 2024, Evan Roberts, Chief Operating Officer of Phreesia Inc, sold 25,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 728,876 shares of Phreesia Inc.
Phreesia Inc (PHR, Financial) is a company that provides a comprehensive patient intake management platform. The platform is designed to automate the patient intake process, improve patient engagement, and enhance the overall healthcare experience.
The insider transaction history for Phreesia Inc indicates that there have been no insider buys over the past year, while there have been 68 insider sells during the same period. Over the past year, Evan Roberts has sold a total of 110,157 shares and has not purchased any shares.
On the day of the recent sale, shares of Phreesia Inc were trading at $24.09, giving the stock a market cap of $1.426 billion. The stock's GF Value is estimated at $37.92, resulting in a price-to-GF-Value ratio of 0.64. This suggests that the stock is significantly undervalued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
